Taniya Charoensareerat

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Authors reply: "Levetiracetam dosing in critically ill patients receiving prolonged intermittent renal replacement therapy".

Authors reply: "Levetiracetam dosing in critically ill patients receiving prolonged intermittent renal replacement therapy".

Journal: Journal of critical care
Published: October 05, 2025

Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.

Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.

Journal: Nephrology (Carlton, Vic.)
Published: August 19, 2025

Extemporaneous Preparation and Effectiveness of Low-Dose Naltrexone for the Treatment of Uremic Pruritus: A Literature Review and Case Report.

Extemporaneous Preparation and Effectiveness of Low-Dose Naltrexone for the Treatment of Uremic Pruritus: A Literature Review and Case Report.

Journal: Pharmacy (Basel, Switzerland)
Published: May 27, 2025

Levetiracetam dosing in critically ill patients receiving prolonged intermittent renal replacement therapy.

Levetiracetam dosing in critically ill patients receiving prolonged intermittent renal replacement therapy.

Journal: Journal of critical care
Published: May 20, 2025

Impact of Removing Race Coefficient from Glomerular Filtration Rate Estimation Equations on Antidiabetics Among Black Patients.

Impact of Removing Race Coefficient from Glomerular Filtration Rate Estimation Equations on Antidiabetics Among Black Patients.

Journal: Pharmacy (Basel, Switzerland)
Published: December 26, 2024

Intraperitoneal daptomycin dosing for peritonitis may be inadequate: a Monte Carlo simulation approach to optimize dosing and outcomes.

Intraperitoneal daptomycin dosing for peritonitis may be inadequate: a Monte Carlo simulation approach to optimize dosing and outcomes.

Journal: Journal of chemotherapy (Florence, Italy)
Published: September 25, 2024

Optimizing fosfomycin dosing regimens in critically ill patients with and without continuous renal replacement therapy.

Optimizing fosfomycin dosing regimens in critically ill patients with and without continuous renal replacement therapy.

Journal: Journal of critical care
Published: August 24, 2024

Lacosamide dosing in patients receiving continuous renal replacement therapy.

Lacosamide dosing in patients receiving continuous renal replacement therapy.

Journal: Journal of intensive care
Published: September 20, 2023

Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach.

Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach.

Journal: Clinical pharmacology : advances and applications
Published: April 14, 2023

What is the right gentamicin dose for multiple trauma patients? A Monte Carlo simulation exploration study.

What is the right gentamicin dose for multiple trauma patients? A Monte Carlo simulation exploration study.

Journal: International journal of critical illness and injury science
Published: March 13, 2023

Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy.

Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy.

Journal: Seminars in dialysis
Published: September 06, 2022

Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.

Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.

Journal: Blood purification
Published: March 26, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026